Design and Development of IoT and Deep Ensemble Learning Based Model for Disease Monitoring and Prediction.

With the rapidly increasing reliance on advances in IoT, we persist towards pushing technology to new heights. From ordering food online to gene editing-based personalized healthcare, disruptive technologies like ML and AI continue to grow beyond our wildest dreams. Early detection and treatment through AI-assisted diagnostic models have outperformed human intelligence. In many cases, these tools can act upon the structured data containing probable symptoms, offer medication schedules based on the appropriate code related to diagnosis conventions, and predict adverse drug effects, if any, in accordance with medications. Utilizing AI and IoT in healthcare has facilitated innumerable benefits like minimizing cost, reducing hospital-obtained infections, decreasing mortality and morbidity etc. DL algorithms have opened up several frontiers by contributing towards healthcare opportunities through their ability to understand and learn from different levels of demonstration and generalization, which is significant in data analysis and interpretation. In contrast to ML which relies more on structured, labeled data and domain expertise to facilitate feature extractions, DL employs human-like cognitive abilities to extract hidden relationships and patterns from uncategorized data. Through the efficient application of DL techniques on the medical dataset, precise prediction, and classification of infectious/rare diseases, avoiding surgeries that can be preventable, minimization of over-dosage of harmful contrast agents for scans and biopsies can be reduced to a greater extent in future. Our study is focused on deploying ensemble deep learning algorithms and IoT devices to design and develop a diagnostic model that can effectively analyze medical Big Data and diagnose diseases by identifying abnormalities in early stages through medical images provided as input. This AI-assisted diagnostic model based on Ensemble Deep learning aims to be a valuable tool for healthcare systems and patients through its ability to diagnose diseases in the initial stages and present valuable insights to facilitate personalized treatment by aggregating the prediction of each base model and generating a final prediction.

Fusion of Graph and Tabular Deep Learning Models for Predicting Chronic Kidney Disease.

Chronic Kidney Disease (CKD) represents a considerable global health challenge, emphasizing the need for precise and prompt prediction of disease progression to enable early intervention and enhance patient outcomes. As per this study, we introduce an innovative fusion deep learning model that combines a Graph Neural Network (GNN) and a tabular data model for predicting CKD progression by capitalizing on the strengths of both graph-structured and tabular data representations. The GNN model processes graph-structured data, uncovering intricate relationships between patients and their medical conditions, while the tabular data model adeptly manages patient-specific features within a conventional data format. An extensive comparison of the fusion model, GNN model, tabular data model, and a baseline model was conducted utilizing various evaluation metrics, encompassing accuracy, precision, recall, and F1-score. The fusion model exhibited outstanding performance across all metrics, underlining its augmented capacity for predicting CKD progression. The GNN model's performance closely trailed the fusion model, accentuating the advantages of integrating graph-structured data into the prediction process. Hyperparameter optimization was performed using grid search, ensuring a fair comparison among the models. The fusion model displayed consistent performance across diverse data splits, demonstrating its adaptability to dataset variations and resilience against noise and outliers. In conclusion, the proposed fusion deep learning model, which amalgamates the capabilities of both the GNN model and the tabular data model, substantially surpasses the individual models and the baseline model in predicting CKD progression. This pioneering approach provides a more precise and dependable method for early detection and management of CKD, highlighting its potential to advance the domain of precision medicine and elevate patient care.